Literature Review of Cognitive Developmental Interventions on Patients with Breast Cancer undergoing Chemotherapy

항암화학요법 유방암환자의 인지기능 증진 중재에 대한 논문 분석

  • Received : 2010.11.15
  • Accepted : 2011.01.29
  • Published : 2011.02.28


Purpose: The purpose of this study was to analyze the trend of cognitive developmental interventions on patients with breast cancer who underwent chemotherapy. Methods: The researcher searched databases and selected 17 literatures using chemotherapy, breast cancer, cognitive function and intervention as searching key words. Searched databases included Ovid, Pubmed, Proquest and Medline and data collection period was from January 2000 to May 2010. Results: Interventions for patients with breast cancer have been continuously developed and frequent research topics included breast cancer, chemotherapy, quality of life, and cognitive function. In terms of study design, four research articles were pre-experimental study designs, one was case study, and the rest of studies were non-equivalent pretest-posttest control group design. Effects of intervention were examined in only 5 studies among 17. The interventions were not found to have direct effects in cognitive improvement. Conclusion: It is needed to figure out the mechanism of cognitive deterioration of the patients with breast cancer who underwent chemotherapy. And nursing interventions needs to be developed in order to hold up the cognitive downhill and help their cognitive rehabilitation.


  1. Kang JJ. Effects of cognitive function enhancement program: focusing on working memory [master]. Seoul: Seoul National University;2008.
  2. Downie FP, Mar Fan HG, Houede-tchen N, Yi Q, Tannock IF. Cognitive function, fatigue, and menopausal symptoms in breast cancer patients receiving adjuvant chemotherapy: evaluation with patient interview after formal assessment. Psychooncology 2006;15:921-30.
  3. Vardy J, Wefel JS, Ahles T, Tannock IF, Schange SB. Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop. Ann Oncol 2008;19:623-9.
  4. Bender CM, Pacella BA, Sereika SM, Brufsky AM, Vogel VG, Rastogi P, et al. What do perceived cognitive problems reflect? J Support Oncol 2008;6:238-42.
  5. O'Shaughnessy JA. Effects of epoetin alfa on cognitive function, mood,asthenia, and quality of life in women with breast cancer undergoing adjuvant chemotherapy. Clin Breast Cancer 2002;3:S116-20.
  6. Schilder CM, Eggens PC, Seynavev C, Linn SC, Gundy CM, Beex LV, et al. Neuropsychological functioning in postmeno: cross-sectional findings from the neuropsychological TEAM-side study. Pausal breast cancer patients treated with tamoxifen or exemestane after AC-chemotherapy. Acta Oncol 2009;48:76-85.
  7. Biegler KA, Chaoul MA, Cohen L. Cancer, cognitive impairment, and meditation. Acta Oncol 2009;48:18-26.
  8. Vetto IP, Vetto JT, Cognitive Dysfunction in Cancer Patients: An educational needs area improved by a single intervention. J Cancer Educ 2007;22:197-201.
  9. Freeman JR, Broshek DK. Assessing cognitive dysfunction in breast cancer: what are the tools? Clin Breast Cancer 2002;3:S91-9.
  10. Jenkins V, Shilling V, Fallowfield, Howell A, hutton S. Does hormone therapy for the treatment of breast cancer have a detrimental effect on memory and cognition? A pilot study. Psychooncology 2004;13:61-6.
  11. Mulrooney T. Cognitive impairment after breast Cancer treatment. Clin J Oncol Nurs 2008;12:678-80.
  12. Ferguson RJ, Ahles TA, Saykin AJ, McDonald BC, Furstcnberg CT, Cole BF, et al. Cognitive-behavioral management of chemotherapy-related cognitive change. Psychooncology 2007;16:772-7.
  13. Jim HS, Donovan KA, Small BJ, Andrykowski MA, Munster PN, Jacobsen PB. Cognitive functioning in breast cancer survivors: a controlled comparison. Cancer 2009;115:1776-83.
  14. Bell M, Bryson G, Wexler BE. Cognitive remediation of working memory deficits: durability of training effects in severely impaired and less severely impaired schizophrenia. Acta Psychiatr Scand 2003;108:101-9.
  15. Cahn-Weiner AD, Malloy FP, Rebok WG, Ott RB. Results of a randomized placebo-controlled study of memory training for mildly impaired Alzheimer's disease patients. Appl Neuropsychol 2003;10:215-23.
  16. Gorman P, Dayle R, Hood CA, Rumr ell L. Effectiveness of the ISAAC cognitive prosthetic system for improving rehabilitation outcomes with neurofunctional impairment. NeuroRehabilitation 2003;18:57-67.
  17. Edelman S, Bell DR, Kidman AD. A group cognitive behaviour therapy programme with metastatic breast cancer patients. Psychooncology 1999;8:295-305.<295::AID-PON386>3.0.CO;2-Y
  18. Si JY. The effects of chronic schizophrenia patients' symptoms and cognitive functions on their social functions [master]. Gyeongbuk: Catholic University of Daegu;2009.
  19. Bender CM, Sereika SM, Berga SL, Vogel VG, Brufsky AM, Paraska KK, et al. Cognitive impairment associated with adjuvant therapy in women with breast cancer. Psychooncology 2006;15:422-30.
  20. Marino P, Roche H, Biron P, Janvier M, Spaeth D, Fabbro M, et al. Deterioration of quality of life high-risk breast cancer patients treated with high-dose chemotherapy: the PEGASE 01 quality of life study. Value Health 2008;11:709-18.
  21. Lemieux J, Maunsell E, Provencher L. Chemotherapy-induced alopecia effects on quality of life among women with breast cancer: a literature review. Psychooncology 2008;17:317-28.
  22. Jansen SJ, Otten W, van de Velde CJ, Nortier JW, Stiggelbout AM. The impact of the percetption of treatment choice on satisfaction with treatment, experienced chemotherapy burden and current quality of life. Br J Cancer 2004;91:56-61.